mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.04 |